News
The drug is expected to be formally approved by the European Commission this year. View on euronews ...
A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...
5don MSNOpinion
Opinion: We can’t win the fight to end HIV if we cut funding and access to medication
Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...
A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...
A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
3d
News-Medical.Net on MSNFunding cuts threaten decades of progress in the fight against HIV
Countries worldwide must step up to support the fight against HIV or face the “ticking time bomb” left by the wholesale ...
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence rates compared to other PrEP medications and with minimal side effects.
Arizona organizations are working hard to provide testing and education for HIV/AIDS programs, but despite medical ...
Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...
The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV by 96 percent The Food and Drug Administration has approved a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results